By Sarah Gaffen and Curt Horvath Drs. Gaffen and Horvath are the President and President-Elect of the Cytokine Society September 3, 2025 IT’S ALMOST HERE, CYTOKINES2025! As the summer winds down and the academic year approaches, THE Cytokine event of the year is rapidly approaching. So much has happened to [READ MORE]
As you pick up your badge and settle into that first session, everything appears to run like clockwork. The venue is perfectly appointed, the speakers are ready, the technology works seamlessly, and the coffee is hot. What you might not realize is the intricate orchestration that began more than a [READ MORE]
I currently work at the Center for Immunology Marseille Luminy (CIML) in Marseille, France where I lead the team “Innate immunity at mucosal sites”. In our team we are interested in understanding innate immune responses in the intestine, and in particular how immune cells, epithelial cells and microbes communicate during [READ MORE]
ClinicalTrials.gov ID NCT07040943 Sponsor West China Hospital Information provided by Xingchen Peng, West China Hospital (Responsible Party) Last Update Posted 2025-07-01 Brief Summary This study aims to investigate the safety and efficacy of the IL-22BP in patients with refractory malignant solid tumors. Detailed Description Cancer is a leading global cause [READ MORE]
ClinicalTrials.gov ID NCT06787222 Sponsor Hasanuddin University Information provided by Rini Amanda Carolina Saragih, Hasanuddin University (Responsible Party) Last Update Posted 2025-01-27 Brief Summary The goal of this clinical trial is to investigate the effectivity and safety of mild to moderate acne vulgaris therapy using Zingiber officinale 5 % transdermal patch. [READ MORE]
ClinicalTrials.gov ID NCT05309616 Sponsor Yale University Information provided by Yale University (Responsible Party) Last Update Posted 2025-02-25 Brief Summary The purpose of this phase 2 study is to examine if inhibiting IL-17A activation using the biologic drug Taltz, in idiopathic subglottic stenosis patients will decrease scar fibroblast proliferation therefore reducing [READ MORE]
Recent Achievements Among Cytokines 2025 Speakers demonstrate the caliber of research being presented at Cytokines 2025, spanning breakthrough discoveries in innate immunity, novel therapeutic targets, and translational research with real clinical potential. The combination of established leaders and rising stars ensures attendees will hear about the most cutting-edge developments in [READ MORE]
We are delighted to congratulate Cytokine Society member Dr. Adriana Forero on receiving the highly competitive Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease (PATH) Award. This prestigious $505,000 five-year award recognizes exceptional researchers with demonstrated potential to advance our understanding of infectious disease pathogenesis, with a current [READ MORE]
In our lab we investigate immunology and homeostasis of the brain in health and disease by using multidisciplinary approaches of neurobiology, immunology, and epigenetics. Our long-term research goal is to understand the role of immune mechanisms in brain health and disease, and to develop new preventive/interventional treatment for chronic brain [READ MORE]
Molecular Insights Into MR1-Mediated T Cell Immunity: Lessons Learned and Unanswered Questions. PMID: 40338831 Awad W, Abdelaal MR, Letoga V, McCluskey J, Rossjohn J. Immunol Rev. 2025 May;331(1):e70033. doi: 10.1111/imr.70033.PMID: 40338831 Free PMC article. Review. The diversity of CD8+ T cell dysfunction in cancer and viral infection. PMID: 40216888 Galluzzi [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
